Revisiting tumor vasculature in the era of cancer immunotherapy: from aberrant hallmark to therapeutic target
- DOI
- 10.1016/j.canlet.2026.218824
- Published
- 2026-11
- Container
- Cancer Letters
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.canlet.2026.218824,
title = {Revisiting tumor vasculature in the era of cancer immunotherapy: from aberrant hallmark to therapeutic target},
author = {Xiang Fang and Fanqi Wang and Haiman Li and Ping Xiao and Mengru Wang and Nan Wu and Xiaohong Yao and Yu Shi},
year = {2026},
journal = {Cancer Letters},
doi = {10.1016/j.canlet.2026.218824},
url = {https://doi.org/10.1016/j.canlet.2026.218824}
}RIS
TY - JOUR TI - Revisiting tumor vasculature in the era of cancer immunotherapy: from aberrant hallmark to therapeutic target AU - Xiang Fang AU - Fanqi Wang AU - Haiman Li AU - Ping Xiao AU - Mengru Wang AU - Nan Wu AU - Xiaohong Yao AU - Yu Shi PY - 2026 JO - Cancer Letters DO - 10.1016/j.canlet.2026.218824 UR - https://doi.org/10.1016/j.canlet.2026.218824 ER -
APA
Fang, X., Wang, F., Li, H., Xiao, P., Wang, M., Wu, N., Yao, X., & Shi, Y. (2026). Revisiting tumor vasculature in the era of cancer immunotherapy: from aberrant hallmark to therapeutic target. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218824
Source records
- crossref · retrieved 2026-09-26T02:58:52.104Z